Pharmalicensing, a division of UTEK Europe Ltd, is pleased to announce the launch of its new online platform, Medical Device Licensing (www.medicaldevicelicensing.com).
For the last twelve years Pharmalicensing has offered users a unique online platform which enables the international biopharmaceutical, lifescience & healthcare industries to identify and engage with prospective licensing, marketing and discovery/development partners around the world.
Over this time companies utilizing Pharmalicensing's services have expanded beyond traditional pharma/biopharma industry to encompass all aspects of the healthcare and lifescience industries. Many of these companies are focused within specialized areas within the healthcare industry - it is for these organizations that Medical Device Licensing has been launched.
The site's unique services complement and enhance business development activity throughout the deal making process. The creation of a corporate Profile on the platform unveils company's partnering requirements to a focused and targeted audience of the key decision-makers within the healthcare industry. In addition to the Profiles, Medical Device Licensing provides the Partner Search Service; which analyzes the needs of a client, creating a "Prospect List" of pre-qualified, potential partners, coordinating company introductions and handling deal negotiations.
"We are very excited by the launch of Medical Device Licensing" commented Mark McBride, Director of UTEK Europe Ltd. "Many companies who have not had access to such a dedicated industry platform to promote and explore their device, diagnostic, delivery and equipment partnering opportunities will be delighted by the launch of the service. They will be able to expand their partnering activities far beyond the current 180,000+ visitors that utilize our Pharmalicensing.com platform every month and take full advantage of a whole new community drawn into Medical Device Licensing".
The site is the third for UTEK in the healthcare sector (alongside pharmalicensing.com and genericlicensing.com) and represents an online global resource for open innovation, partnering, licensing and business development within the medical device industry.
Visit medicaldevicelicensing.com
The challenges of the economic downturn stimulated London Biotech Network to build innovative new partnerships at Genesis last year.
The resultant exciting mix of business and science is something many have only dreamed of. This will be retained for 2009 with a streamlined approach for delegates to maximise the return on your investment in participating.
Known as the biggest UK bioscience event of the year, the exhibition will run over 2 days (10th and 11th Dec 2009) and will showcase some of the UK's most promising and innovative new companies.
Find out more and register
BioBusiness Exchange (UKTI) - 9th December
Running alongside Genesis, The Biotechnology Business Exchange 2009 hosted by UKTI, will be held on the 9th December in London. This is a unique opportunity to meet one-to-one with some of the most innovative and creative UK based companies across the life science sector.
Email for more information
Pharmalicensing is pleased to announce the launch of a new website, http://thefutureofinnovation.org. The initiative represents a unique project which was conceived by innovation experts Drs. Bettina von Stamm, UK and Anna Trifilova, Russia and is proudly sponsored by Pharmalicensing.
The Future of Innovation website along with its sister publication of the same name which is to be released by Gower Books this Autumn, represents a community of over 350 leading thinkers in over 60 countries from business, government, consulting and academia who are sharing their thoughts, experiences, dreams, visions, hopes, concerns, and passions around the future of innovation.
Seeking experienced distributors for numerous available pharmaceutical prescription products in Hong Kong, China and Korea.
Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Hong Kong and China.
More
Seeking late stage/launched CNS products, specifically indicated for Parkinson’s disease, dementia, bi-polar disorder and addiction.
Our Spanish based company is looking to acquire late stage or launched CNS products particularly in the areas of Parkinson disease, addiction, bi-polar disorder and schizophrenia.
More
Unique advanced herbal product indicated for the treatment of ischaemic heart condition, diabetes, diabetic lesions and circulatory diseases as well.
Our client has developed and tested a unique advanced herbal formulation capable of reverting ischaemic heart conditions and complications associated with diabetic foot; as well as re-establishing blood flow in circulatory pathologies.
More
Pharmalicensing now offers expert support to assist and guide you through the entire deal negotiation process.
From the moment you select your partner, Pharmalicensing can help you with initial discussions, preparation of introductory material and suitable deal structure implementation, amongst other things.
Find out more about Deal Negotiation servicesClients in focus...
The client is seeking late stage oral anti-diabetic products. More
View more in-licensing needs
Enriched NK cell populations and method of treating malignancies or prevent recurrence of malignancies and treating any hyperproliferative disorders with these enriched compositions More
View more out-licensing opportunities
Biopelle, Inc. is an aesthetics specialty company developing a unique product portfolio designed to improve the health and appearance of the skin. More
View more profiled companies